Discontinuation of medication after delivery is not recommended for pregnant women with hepatitis B on antiviral therapy. It is not recommended that pregnant women on antiviral therapy for hepatitis B stop taking the medication after delivery, because stopping the medication may lead to a recurrence of hepatitis B, and may even lead to the development of severe hepatitis. If hepatitis B carriers in the second trimester of pregnancy to perform mother-to-child blockade of oral antiviral drugs, after delivery is allowed to stop breastfeeding. As to whether hepatitis B patients need to stop taking medication, it is recommended to go to the infectious diseases department or hepatology department of regular medical institutions, and continue to review liver function, quantitative hepatitis B five indexes, hepatitis B DNA, liver ultrasound and other relevant indicators. The specialist physician according to the patient’s specific condition to decide, do not arbitrarily stop the drug. In addition, for hepatitis B patients also need to pay attention to rest, can not stay up late, do not take drugs that have damage to the liver, regular outpatient follow-up.